Frequently Asked Questions
General
What age range is intranasal dexmedetomidine suitable for?
Most evidence and clinical experience is in children aged 6 months to 12 years. Its use in infants under 6 months has limited pharmacokinetic data and requires senior anaesthetist involvement. In adolescents over 12 years, the required dose volume may become impractical and alternative approaches are usually preferred.
Can it be used in children with a cold or runny nose?
Nasal congestion significantly reduces absorption across the nasal mucosa. For non-urgent procedures, it is preferable to wait until the child has recovered. If proceeding is necessary, administering saline nasal drops 5 minutes beforehand may improve absorption. Discuss the plan with the responsible clinician and document the rationale.
Can it be used as the sole agent for painful procedures?
Intranasal dexmedetomidine provides anxiolysis and mild analgesia — it is not reliable as the primary analgesic agent for significantly painful procedures. It is well-suited to procedures where anxiety and movement are the main challenges (MRI, IV cannulation, wound inspection). For painful procedures, ensure adequate analgesia is planned separately (topical anaesthetic, local infiltration, oral analgesia).
Is intranasal dexmedetomidine the same as oral or intravenous dexmedetomidine?
The active drug is the same, but the route of administration affects the onset, bioavailability, and clinical profile. Intranasal dexmedetomidine has a bioavailability of approximately 65–82%, with onset of 20–45 minutes. Intravenous dexmedetomidine has faster onset but requires cannulation first.
Dosing
How do I calculate the dose?
Use 1–2 mcg/kg for premedication and most procedural sedation, and 2–3 mcg/kg for imaging sedation such as MRI. The maximum dose is 100 mcg regardless of weight. Divide the calculated volume equally between both nostrils.
Example: 15 kg child for MRI at 2 mcg/kg → 30 mcg → 0.3 mL total → 0.15 mL per nostril.
What concentration should I use?
Use the 200 mcg/2 mL (100 mcg/mL) preparation undiluted. Diluting the preparation increases the volume delivered intranasally and reduces efficacy — drug that does not stay on the nasal mucosa drains into the pharynx and is swallowed.
How long before the procedure should I give it?
Administer 30–45 minutes before the procedure or induction of anaesthesia. For MRI, allow 45 minutes as the child needs to be fully settled before entering the scanner.
Administration
Do I need to use a MAD device?
Yes. The Mucosal Atomiser Device (MAD Nasal™) converts the liquid to a fine mist that distributes across the nasal mucosa. Dripping or squirting the liquid without atomisation results in poor mucosal contact and unpredictable absorption.
What if the child cries or sneezes after the dose?
Some drug loss is expected if the child is distressed. The most important things are to note what happened and wait the full 45 minutes before concluding that sedation is inadequate. A calm environment — dim lights, parent holding the child, distraction — helps reduce distress at administration. If significant drug loss occurred, a repeat dose may be considered after senior review — see Troubleshooting.
Can the full dose be given to one nostril?
For volumes ≤0.5 mL, administration to a single nostril is acceptable. For larger volumes, dividing the dose equally between both nostrils is preferred to maximise mucosal contact area and reduce drainage.
Monitoring
Where should the child be monitored?
In any setting where intranasal dexmedetomidine is administered, the following must be available:
- Continuous pulse oximetry
- Blood pressure measurement capability
- Supplemental oxygen
- Suction
- Bag-mask ventilation equipment
- Immediate access to a clinician trained in paediatric airway management
The child must not be left unattended once sedation has begun.
How long do we need to monitor after the procedure?
Until all discharge criteria are met — see Monitoring. As a minimum, observe for 60 minutes from the time of administration, even if the child appears to have recovered fully.
Can the child go home after intranasal dexmedetomidine?
Yes, once discharge criteria are met. Carers must be advised that the child may remain drowsy for several hours and should not be left unsupervised near water, heights, roads, or stairs. The child should not return to school or childcare on the day of sedation.
Safety
What if sedation is deeper than expected?
Stimulate the child and reposition. Apply supplemental oxygen. Notify the medical officer. There is no pharmacological reversal agent — management is supportive. This is why appropriate monitoring and resuscitation equipment must be in place before administration. See Troubleshooting.
Can it be given alongside other sedatives?
Concurrent use of opioids, benzodiazepines, antihistamines, or other sedatives significantly increases the risk of excessive sedation and respiratory compromise. Any co-administration requires explicit senior medical review and careful dose adjustment. Document the rationale clearly.
Is it safe in children with congenital heart disease?
Children with haemodynamically significant congenital heart disease should be assessed individually by a senior anaesthetist or cardiologist before use. The haemodynamic effects of dexmedetomidine (bradycardia, mild hypotension) may be poorly tolerated in some cardiac lesions. Simple, corrected, or mild lesions are generally lower risk.